✦ LIBER ✦

Long-Term Efficacy of Interleukin-1 Receptor Antagonist (Anakinra) in Corticosteroid-Dependent and Colchicine-Resistant Recurrent Pericarditis

✍ Scribed by Finetti, Martina; Insalaco, Antonella; Cantarini, Luca; Meini, Antonella; Breda, Luciana; Alessio, Maria; D'Alessandro, Matteo; Picco, Paolo; Martini, Alberto; Gattorno, Marco

Book ID: 122134092
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 340 KB
Volume: 164
Category: Article
ISSN: 1097-6833
DOI: 10.1016/j.jpeds.2014.01.065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of an Interleukin-1β Receptor A

Efficacy of an Interleukin-1β Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis

✍ Alessandra Scardapane, Antonio Brucato, Francesco Chiarelli… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 172 KB

PReS-FINAL-2333: Long term efficacy of i

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis

✍ Finetti, M; Insalaco, A; Cantarini, L; D'Alessandro, M; Meini, A; Breda, L; Ales 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 99 KB

Successful treatment of idiopathic recur

Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): An unrecognized autoinflammatory disease?

✍ Paolo Picco; Giacomo Brisca; Francesco Traverso; Anna Loy; Marco Gattorno; Alber 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Long-term efficacy of the interleukin-1

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome

✍ Bénédicte Neven; Isabelle Marvillet; Celine Terrada; Alice Ferster; Nathalie Bod 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 2 views

Long-term safety and maintenance of clin

Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double-blind, placebo-controlled trial

✍ George Nuki; Barry Bresnihan; Moraye B. Bear; Dorothy McCabe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 3 views